Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

被引:124
|
作者
Qadri, Firdausi [1 ]
Wierzba, Thomas F. [3 ]
Ali, Mohammad [3 ,4 ]
Chowdhury, Fahima [1 ]
Khan, Ashraful I. [1 ]
Saha, Amit [1 ]
Khan, Iqbal A. [2 ]
Asaduzzaman, Muhammad [1 ]
Akter, Afroza [1 ]
Khan, Arifuzzaman [1 ]
Begum, Yasmin A. [1 ]
Bhuiyan, Taufiqur R. [1 ]
Khanam, Farhana [1 ]
Chowdhury, Mohiul I. [1 ]
Islam, Taufiqul [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
You, Young A. [3 ]
Kim, Deok R. [3 ]
Siddik, Ashraf U. [1 ]
Saha, Nirod C. [1 ]
Kabir, Alamgir [1 ]
Cravioto, Alejandro [3 ]
Desai, Sachin N. [3 ]
Singh, Ajit P. [3 ]
Clemens, John D. [1 ,5 ]
机构
[1] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh
[2] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh
[3] Int Vaccine Inst, Seoul, South Korea
[4] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[5] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 18期
关键词
O1; DHAKA;
D O I
10.1056/NEJMoa1510330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. We conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic. METHODS Nonpregnant residents of Dhaka, Bangladesh, who were 1 year of age or older were randomly assigned to receive a single dose of oral cholera vaccine or oral placebo. The primary outcome was vaccine protective efficacy against culture-confirmed cholera occurring 7 to 180 days after dosing. Prespecified secondary outcomes included protective efficacy against severely dehydrating culture-confirmed cholera during the same interval, against cholera and severe cholera occurring 7 to 90 versus 91 to 180 days after dosing, and against cholera and severe cholera according to age at baseline. RESULTS A total of 101 episodes of cholera, 37 associated with severe dehydration, were detected among the 204,700 persons who received one dose of vaccine or placebo. The vaccine protective efficacy was 40% (95% confidence interval [CI], 11 to 60%; 0.37 cases per 1000 vaccine recipients vs. 0.62 cases per 1000 placebo recipients) against all cholera episodes, 63% (95% CI, 24 to 82%; 0.10 vs. 0.26 cases per 1000 recipients) against severely dehydrating cholera episodes, and 63% (95% CI, -39 to 90%), 56% (95% CI, 16 to 77%), and 16% (95% CI, -49% to 53%) against all cholera episodes among persons vaccinated at the age of 5 to 14 years, 15 or more years, and 1 to 4 years, respectively, although the differences according to age were not significant (P = 0.25). Adverse events occurred at similar frequencies in the two groups. CONCLUSIONS A single dose of the oral cholera vaccine was efficacious in older children (= 5 years of age) and in adults in a setting with a high level of cholera endemicity.
引用
收藏
页码:1723 / 1732
页数:10
相关论文
共 50 条
  • [21] ORAL CHOLERA VACCINE STUDIES IN HIGH CHOLERA ENDEMIC SETTINGS IN BANGLADESH
    Qadri, Firdausi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 5 - 5
  • [22] Oral Cholera Vaccine Efficacy and Effectiveness
    Song, Katerina Rok
    Lim, Jacqueline Kyungah
    Park, Se Eun
    Saluja, Tarun
    Cho, Sung-Il
    Wartel, Tram Anh
    Lynch, Julia
    VACCINES, 2021, 9 (12)
  • [23] Efficacy of a novel single-dose oral antibiotic for urogenital gonorrhoea
    Annette Fenner
    Nature Reviews Urology, 2019, 16 : 66 - 66
  • [24] Efficacy of a novel single-dose oral antibiotic for urogenital gonorrhoea
    Fenner, Annette
    NATURE REVIEWS UROLOGY, 2019, 16 (02) : 66 - 66
  • [25] SINGLE-DOSE EFFICACY AND SAFETY OF ZINDOTRINE, A NEW ORAL BRONCHODILATOR
    KRADJAN, WA
    HUDSON, LD
    HARRIS, DM
    EMMICK, GA
    PIERSON, DJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (10): : 760 - 763
  • [26] EFFICACY OF SINGLE-DOSE ORAL FLUCONAZOLE IN THE TREATMENT OF VULVOVAGINAL CANDIDIASIS
    OTUBU, JAM
    IMADE, GE
    SAGAY, AS
    TOWOBOLA, OA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (04): : 632 - 637
  • [27] Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh
    Qadri, Firdausi
    Azad, Abul Kalam
    Flora, Meerjady Sabrina
    Khan, Ashraful Islam
    Islam, Md Taufiqul
    Nair, G. Balakrish
    Singh, Poonam Khetrapal
    Clemens, John D.
    LANCET, 2018, 391 (10133): : 1877 - 1879
  • [28] Single-dose azithromycin for the treatment of cholera in adults
    Saha, Debasish
    Karim, Mohammad M.
    Khan, Wasif A.
    Ahmed, Sabeena
    Salam, Mohammed A.
    Bennish, Michael L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23): : 2452 - 2462
  • [29] Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR
    Lagos, R
    Fasano, A
    Wasserman, SS
    Prado, V
    Martin, OS
    Abrego, P
    Losonsky, GA
    Alegria, S
    Levine, MM
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05): : 1709 - 1712
  • [30] Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine
    Sharma, Tarun
    Joshi, Neeraj
    Mandyal, Ashwani Kumar
    Nordqvist, Stefan L.
    Lebens, Michael
    Kanchan, Vibhu
    Lofstrand, Madeleine
    Jeverstam, Frida
    Ahasan, Mohammad Mainul
    Khan, Imran
    Karim, Mahbubul
    Muktadir, Hasneen
    Muktadir, Abdul
    Gill, Davinder
    Holmgren, Jan
    VACCINE, 2020, 38 (50) : 7998 - 8009